戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                     Male C57BL/6, wild-type, toll-like receptor 2-/-.
2 as pathogen-associated molecular patterns by Toll-like receptor 2.
3  C. glutamicumDeltamptD mutants, to activate Toll-like receptor 2.
4 feri was mediated primarily by activation of Toll-like receptor 2.
5 bs specific for the innate immunity receptor Toll-like receptor 2.
6 tivation of antigen-presenting cells through Toll-like receptor 2.
7 , heat shock protein 70 also signals through Toll-like receptor 2.
8  PILAM, mediates its biological activity via Toll-like receptor 2.
9 receptors expressed by macrophages, CD36 and toll-like receptor 2.
10 wide variety of pathogens likely detected by Toll-like receptor 2.
11 l stimulated HEK-293 cells expressing either Toll-like receptor 2/1 (TLR2/1) or TLR2/6, but only HspX
12                   By directly downregulating Toll-like receptor 2/1 heterodimer (TLR2/1)-induced CYP2
13 kin-8 secretion, which did not occur through Toll-like receptor 2, 2/6, 4, or 5 stimulation.
14 r or father, IL-10 production in response to Toll-like receptor 2, 3, and 4 agonists, ovalbumin, salm
15 h healthy control subjects after exposure to toll-like receptor 2, 3, or 4 agonists or exposure to UV
16 igh-iron conditions had reduced responses to Toll-like receptor-2, -3, and -4 agonists, which associa
17 ugh pattern recognition receptors, including Toll-like receptors 2, 4, and 9.
18                                   Neutrophil Toll-like receptor 2, -4, and -9 expression and cytokine
19    Histone toxicity on glomeruli ex vivo was Toll-like receptor 2/4 dependent, and lack of TLR2/4 att
20                           JQ1 also inhibited toll-like receptors 2/4 (TLR2/4) expression and nuclear
21             Increased NOX2 assembly required Toll-like receptors 2/4 and MyD88 signaling, which are k
22  treatment with a synergistic combination of Toll-like receptor 2/6 (TLR 2/6) and TLR9 agonists (Pam2
23               Both strains engaged with host Toll-like receptor 2/6 (TLR2/6), TLR2-CD14, and TLR5 to
24                  The innate immune receptor, Toll-like receptor 2/6 heterodimer, is exploited by Sb(R
25 lipids that have been previously reported as Toll-like receptor 2 activators.
26                                              Toll-like receptor 2 agonism activated luminal endotheli
27     Interestingly, maturation of MDLC with a toll-like receptor 2 agonist or transforming growth fact
28  inhibited NF-kappaB induced by IL-1beta and Toll-like receptor 2 agonist Pam3CSK4.
29 2, and IFNgamma upon stimulation with Con A, Toll-like receptor 2 agonist, or anti-CD3 antibodies.
30 es by peripheral monocytes stimulated with a Toll-like receptor 2 agonist.
31                                              Toll-like receptor 2-agonistic lipopeptides typified by
32 nting altered surface exposure or release of Toll-like receptor 2 agonists during rapid growth of Fra
33 or necrosis factor-alpha) following specific Toll-like receptor 2 and 4 (TLR-2/TLR-4) agonist challen
34 eneration and elevated surface expression of toll-like receptor 2 and CD11b on monocytes and neutroph
35 gen-activated kinase signaling downstream of Toll-like receptor 2 and dectin-1 stimulation.
36  with broad specificity that is dependent on Toll-like receptor 2 and interleukin 1beta.
37 se to T. cruzi infection, to be dependent on Toll-like receptor 2 and NF-kappaB.
38 s with previously identified risk alleles in Toll-like receptor 2 and TIRAP was associated with an ad
39  as compared to activation via heterodimeric Toll-like receptor 2 and Toll-like receptor 1 (TLR2/1) b
40  IFN-kappa was significantly increased after toll-like receptor 2 and UVB treatment in lupus keratino
41 s, LPS-induced surface expression of MHC II, Toll-like receptor-2 and -4 were markedly lower (80%, P
42 hoic acid (LTA) and hemoglobin (Hb) requires Toll-like receptors 2 and 4 (TLR2 and -4).
43                                   Rationale: Toll-like receptors 2 and 4 (TLR2, TLR4) enable cellular
44 rance, as evidenced by the downregulation of Toll-like receptors 2 and 4 and of inflammatory cytokine
45 pneumophila resulted in the up-regulation of Toll-like receptors 2 and 4 and the activation of CD40,
46 nate immune activation and signaling through Toll-like receptors 2 and 4 at early times postinfection
47               HMGB1 functions as a ligand of Toll-like receptors 2 and 4 on macrophages, leading to a
48 on of different forms of Candida albicans by Toll-like receptors 2 and 4 on mononuclear leukocytes ha
49              Furthermore, HA signals through Toll-like receptors 2 and 4 to stimulate inflammatory ge
50  HIF IL-6 and IL-8 production independent of Toll-like receptors 2 and 4, receptor for advanced glyca
51  inflammatory immune responses by activating Toll-like receptors 2 and 4, respectively.
52  and OX40L expression on DCs, independent of Toll-like receptors 2 and 4, the NLRP3 inflammasome, and
53 nscription in mouse microglial cells through Toll-like receptors 2 and 4.
54 s NFAT transcription factor independently of Toll-like receptors 2 and 4.
55 e inflammatory condition that is mediated by Toll-like receptors 2 and 6 (TLR2 and TLR6) and which in
56 ia activation of the innate immune receptor, Toll-like receptor 2, and subsequent inflammatory cell i
57                                    Dectin-1, Toll-like receptor 2, and Toll-like receptor 4 expressio
58  ionized calcium-binding adapter molecule 1, toll-like receptor 2, and toll-like receptor 4.
59 en receptors; peptidoglycan, which activates Toll-like receptor 2; and lipopolysaccharide (LPS), whic
60                    The data firmly establish Toll-like receptor 2 as an innate immune sensor for PGN
61 mmasome and the bacterial lipoprotein sensor Toll-like receptor 2, but not in single knockout mice, d
62       As for MALP-2, all were dependent upon Toll-like receptor 2, but unlike MALP-2, they were also
63 AP)-containing) bacteria to demonstrate that Toll-like receptor 2 can recognize peptidoglycan (PGN).
64 osine kinase receptor-1, troponin I, soluble toll-like receptor-2, creatinine, and uric acid.
65 e, the increased arthritis severity of TLR2 (Toll-like receptor 2)-deficient mice was reduced by the
66 e in response is not because of variation in Toll-like receptor 2-dependent activation of the signali
67  in vitro passages induce interleukin-6 in a Toll-like receptor 2-dependent manner.
68 ed disruption of the epithelial barrier in a Toll-like receptor 2-dependent manner.
69  of MMP-9, but not of MMP-1, was found to be Toll-like receptor 2-dependent.
70                                              Toll-like receptor 2 expression was unchanged.
71 ensis infection induces an early increase in Toll-like receptor 2 expression, which facilitates paras
72 ingle-nucleotide polymorphisms (SNPs) in the toll-like receptor 2 gene (TLR2), the toll-like receptor
73 n host and pathogen is driving adaptation of Toll-like receptor 2 genes.
74                                Expression of Toll-like receptor 2 in lung tissue tended to be down-re
75 ciently inhibited the expression of IL-8 and Toll-like receptor 2 in M. furfur-infected human keratin
76 s induce the activation of NF-kappaB through Toll-like receptor 2, independent of enzymatic activity.
77 e are capable of inducing interleukin-6 in a Toll-like receptor 2-independent manner, whereas the dat
78 ntly suppressed T-lymphocyte activation in a Toll-like receptor 2-independent manner.
79            The interaction of F. alocis with Toll-like receptor 2 induced granule exocytosis along wi
80 mmensal bacteria by dendritic cells (through toll-like receptor 2), innate immune responses facilitat
81                                              Toll-like receptor 2 is the most diverse of these recept
82                                        TLR2 (Toll-like receptor 2) is a unique TLR in that it has bee
83 r membrane of A. muciniphila, interacts with Toll-like receptor 2, is stable at temperatures used for
84 nterferon knockout (IFN-gamma(-/-)), BALB/c, Toll-like receptor 2 knockout (TLR2(-/-)), and C57BL/6 m
85 (C3H/HeJ) or toll-like receptor-2 signaling (toll-like receptor-2 knockouts) had similar effects on p
86 r advanced glycation end products (RAGE) and Toll-like receptor 2, leading to local delivery of monoc
87 e skin microbiome is a rich source of LTA, a Toll-like receptor 2 ligand, we mimicked the GF microbio
88 ation factor, and lipoteichoic acid (LTA), a Toll-like receptor 2 ligand.
89 ity of Mtb-derived membrane vesicles bearing Toll-like receptor 2 ligands, including the lipoproteins
90 bed flow and of neutrophils, hyaluronan, and Toll-like receptor 2 ligation in superficial intimal inj
91 Crohn disease-like Card15 mutation increased Toll-like receptor 2-mediated activation of NF-kappa B-c
92 he ability of the whole organism to activate Toll-like receptor 2-mediated MyD88 signaling in macroph
93 ed production of nitric oxide synthase 2 via Toll-like receptor 2-mediated nuclear factor-kappaB acti
94                                              Toll-like receptor 2 mediates apolipoprotein CIII-induce
95 e was also a significant survival benefit in toll-like receptor 2-/- mice compared to wild-type mice.
96           Compared to septic wild-type mice, toll-like receptor 2-/- mice had markedly improved cardi
97                  These favorable outcomes in toll-like receptor 2-/- mice were associated with attenu
98                                Wild-type and toll-like receptor 2-/- mice were divided into sham and
99 ngivalis increased mRNA expressions of NOD2, Toll-like receptor 2, myeloid differentiation primary re
100 d enhance innate immune function and neither toll-like receptor-2 nor toll-like receptor-4 are necess
101 ession of key pattern recognition receptors (Toll-like receptor 2, Nucleotide-binding oligomerization
102       PSA induces and preferentially ligates Toll-like receptor 2 on PDCs but not on conventional DCs
103 f human beta-defensin-2) was not mediated by Toll-like receptor 2 or 4.
104 acrophages deficient in expression of either Toll-like receptor 2 or the Toll-like receptor accessory
105 PBMC cytolysis of leukemic cells, partly via Toll-like receptor-2/protein kinase C/nuclear factor-kap
106 ells, and CD14(+) monocytes that coexpressed Toll-like receptor-2, receptor-3, receptor-4, receptor-5
107  Furthermore, dectin-1 receptors rather than Toll-like receptor 2 receptors were shown to be necessar
108 oline-associated virulence is independent of Toll-like receptor 2 recognition.
109                                  Blocking of Toll-like receptor 2 reduced the strength of the observe
110 implicate flow disturbance, neutrophils, and Toll-like receptor 2 signaling as mechanisms that contri
111 d by PSA during intestinal inflammation, and Toll-like receptor 2 signaling is required for both Treg
112 as not required for IL-8 production and that Toll-like receptor 2 signaling might be affected in the
113                   These studies suggest that toll-like receptor 2 signaling plays a critical role in
114  toll-like receptor-4 signaling (C3H/HeJ) or toll-like receptor-2 signaling (toll-like receptor-2 kno
115 e from myeloid-derived suppressor cells in a Toll-like receptor 2/Stat3-dependent manner.
116                                       Innate Toll-like receptor 2 stimulation promotes formation of r
117 recognition with monoclonal antibody against Toll-like receptor 2 suggests that induction of innate i
118 side a universal T cell helper epitope and a Toll-like receptor 2 targeting lipid moiety to form lipo
119 mune system, the mannose-binding lectin, and Toll-like receptor 2 that both specifies and amplifies t
120 ponse (e.g., tumor necrosis factor alpha and Toll-like receptor 2), the complement system, the respon
121                          While Lpp activates Toll-like receptor 2, the MsbB acyltransferase modifies
122 nts expressed significantly higher levels of Toll-like receptor 2 (TLR-2) and exhibited significantly
123 d to explore the potential interplay between Toll-like receptor 2 (TLR-2) and NOD-2 in joint inflamma
124 er, BDCA1(+) mDCs expressed higher levels of Toll-like receptor 2 (TLR-2) and scavenger receptor A (S
125 s in order to characterize the expression of Toll-like receptor 2 (TLR-2) and TLR-4 and the responses
126  macrophages isolated from mice deficient in Toll-like receptor 2 (TLR-2) but not TLR-4 are resistant
127          The specific interaction of LM with Toll-like receptor 2 (TLR-2) but not with TLR-4 suggeste
128 ity and was completely inhibited by blocking Toll-like receptor 2 (TLR-2) or depleting its mediator M
129        Maltoheptaose activated monocytes via Toll-like receptor 2 (TLR-2) signaling, as discovered by
130  In this study, we delivered signals through Toll-like receptor 2 (TLR-2) to reinvigorate functionali
131 ls, we conducted a study to test the role of Toll-like receptor 2 (TLR-2), TLR-4, and the cytosolic T
132 duce cell death in peritoneal B1a cells from Toll-like receptor 2 (TLR-2)- or NLRP3 inflammasome-defi
133 a range of bacteria and are able to activate Toll-like receptor 2 (TLR-2).
134                                              Toll-like receptor 2 (TLR-2)/TLR-4-mediated innate immun
135 f cultured bone marrow cells with ligands to Toll-like receptor 2 ([TLR-2] zymosan) and TLR-9 (ODN M3
136                                              Toll like receptor 2 (TLR2) recognizes lipids, activates
137           Our studies have demonstrated that Toll-like receptor 2 (TLR2) activation by HSV results in
138                           Here, we show that toll-like receptor 2 (TLR2) activation by intracerebrove
139                        Endothelial cell (EC) Toll-like receptor 2 (TLR2) activation up-regulates the
140 s trigger pro-inflammatory responses through Toll-like receptor 2 (TLR2) activation, and this whether
141  to regulate cytokine release induced by the Toll-like receptor 2 (TLR2) agonist Pam3CSK4.
142  have reported that it can be an agonist for Toll-like receptor 2 (TLR2) and an antagonist or agonist
143 activate innate immune responses by engaging Toll-like receptor 2 (TLR2) and are highly immunostimula
144 reviously, we have reported that ligation of Toll-like receptor 2 (TLR2) and Dectin 1 on antigen-pres
145 how that two pathogen recognition receptors, Toll-like receptor 2 (TLR2) and dectin-1, recognizing th
146                                         Both Toll-like receptor 2 (TLR2) and IL-1 receptor type 1 (IL
147 s and astrocytes through a pathway involving Toll-like receptor 2 (TLR2) and poly(ADP-ribose) polymer
148  antibodies were used to dissect the role of Toll-like receptor 2 (TLR2) and programmed death-ligand
149 e the ability of the innate sensing molecule Toll-like receptor 2 (TLR2) and the signaling molecule M
150 tion was inhibited by blocking antibodies to Toll-like receptor 2 (TLR2) and TLR1, indicating that hu
151        Finally, we observed that killed BCG, Toll-like receptor 2 (TLR2) and TLR4 agonists, and an M
152 se to other proinflammatory stimuli, such as Toll-like receptor 2 (TLR2) and TLR4 agonists.
153  minor reduction in mice doubly deficient in Toll-like receptor 2 (Tlr2) and Tlr4 and normal response
154 naling was TLR-dependent as the knockdown of Toll-like receptor 2 (TLR2) and TLR4 blocked NFkappaB an
155 n and IL-1beta secretion in macrophages upon Toll-like receptor 2 (TLR2) and TLR4 engagement.
156                                              Toll-like receptor 2 (TLR2) and TLR4 expression was dete
157 ratory infections to investigate the role of Toll-like receptor 2 (TLR2) and TLR4 in the host respons
158            This study examined the role that Toll-like receptor 2 (TLR2) and TLR4 may play in pathoge
159     Here we show that miR-302b is induced by Toll-like receptor 2 (TLR2) and TLR4 through ERK-p38-NF-
160 lis, a gram-negative bacterium recognized by Toll-like receptor 2 (TLR2) and TLR4, which are expresse
161 ved features, many viruses are recognized by Toll-like receptor 2 (TLR2) and TLR4.
162 tors of the innate immune system and express Toll-like receptor 2 (TLR2) and TLR4.
163                                              Toll-like receptor 2 (TLR2) and TLR5 have been shown to
164 A. actinomycetemcomitans or P. gingivalis is Toll-like receptor 2 (TLR2) and/or TLR4 dependent.
165 ed, albeit the recognition of lipoglycans by Toll-like receptor 2 (TLR2) appears to be important for
166                                  Agonists of Toll-like receptor 2 (TLR2) are devoid of significant pr
167              Complement Receptor 3 (CR3) and Toll-like Receptor 2 (TLR2) are pattern recognition rece
168 thelial cell lines, we previously identified Toll-like receptor 2 (TLR2) as the principal epithelial
169  have reported that it can be an agonist for Toll-like receptor 2 (TLR2) as well as an antagonist or
170 t VCAN exerts tolerogenic activities through Toll-like receptor 2 (TLR2) binding, the immunoregulator
171 nate immune responses via the utilization of Toll-like receptor 2 (TLR2) but not TLR4.
172 rlying mechanism revealed that activation of Toll-like receptor 2 (TLR2) by curli fibers is critical
173 mplicated in preventing inflammation through Toll-like receptor 2 (TLR2) by inducing expression of th
174                                              Toll-like receptor 2 (TLR2) deficiency enhances murine s
175 e found that OMPC and Hib-OMPC engaged human Toll-like receptor 2 (TLR2) expressed in human embryonic
176 ation in HeLa cells, likely due to a lack of Toll-like receptor 2 (TLR2) expression in these cells.
177 neumococcal clearance was not dependent upon Toll-like receptor 2 (TLR2) expression, oxidative stress
178 tantly, this colitis was highly dependent on Toll-like receptor 2 (TLR2) function since it was suppre
179                                          The Toll-like receptor 2 (TLR2) gene encodes a transmembrane
180                                              Toll-like receptor 2 (TLR2) has been implicated in the o
181             The pattern recognition receptor Toll-like receptor 2 (TLR2) has been implicated in the r
182 morphism in the Toll-IL-1 receptor domain of Toll-like receptor 2 (TLR2) has been linked to increased
183         We examined the inflammatory role of Toll-like receptor 2 (TLR2) in age-related macular degen
184 en gram-positive bacterial superantigens and toll-like receptor 2 (TLR2) in health and critical illne
185                       To examine the role of Toll-like receptor 2 (TLR2) in host defense against Stre
186 ng cluster for the interaction of LipL32 and Toll-like receptor 2 (TLR2) in induced inflammatory resp
187 ycobacterium tuberculosis, to synergize with Toll-like receptor 2 (TLR2) in mediating these responses
188 lipopolysaccharide that supposedly activates toll-like receptor 2 (TLR2) instead of TLR4.
189                                              Toll-like receptor 2 (TLR2) is a pattern recognition rec
190                                              Toll-like receptor 2 (TLR2) is a pattern recognition rec
191                                              Toll-like receptor 2 (TLR2) is a target for immune syste
192                                              Toll-like receptor 2 (TLR2) is an essential mediator of
193                          We report here that Toll-like receptor 2 (TLR2) is expressed by oligodendroc
194                                              Toll-like receptor 2 (Tlr2) is important for its role in
195                                              Toll-like receptor 2 (TLR2) is required for the recognit
196                        We next observed that Toll-like receptor 2 (TLR2) is suppressed in BMMPhi from
197    Although the pattern recognition receptor Toll-like receptor 2 (TLR2) is typically thought to reco
198                   Previously, we showed that Toll-like receptor 2 (TLR2) ligand pretreatment prevente
199 l-(l ysyl)3-lysine (Pam3CysSK4), a synthetic Toll-like receptor 2 (TLR2) ligand, that was given at im
200                           In the intestines, Toll-like receptor 2 (TLR2) mediates immune responses to
201                                              Toll-like receptor 2 (TLR2) mediates the inflammatory re
202                             We found neither Toll-like receptor 2 (TLR2) nor TLR4 nor TLR5 were requi
203 creened for their ability to either activate Toll-like receptor 2 (TLR2) or TLR4 and to antagonize TL
204                   Using CHO cells expressing Toll-like receptor 2 (TLR2) or TLR4, both with transfect
205                         However, eliminating Toll-like receptor 2 (TLR2) permits bacterial replicatio
206                                              Toll-like receptor 2 (TLR2) plays a critical role in hos
207                    Here, we demonstrate that toll-like receptor 2 (TLR2) plays a role in the NK cell-
208                                              Toll-like receptor 2 (TLR2) plays an important role in h
209 he present study was to assess the effect of Toll-like receptor 2 (TLR2) polymorphisms on susceptibil
210 study continues to explore the plasticity of Toll-like receptor 2 (TLR2) previously described in immu
211  respiratory epithelial cells in response to toll-like receptor 2 (TLR2) receptor stimulation.
212 athogen Porphyromonas gingivalis activates a Toll-like receptor 2 (TLR2) response that triggers infla
213                                      Loss of Toll-like receptor 2 (TLR2) resulted in reduced islet ex
214      Both interleukin-1 receptor (IL-1R) and toll-like receptor 2 (TLR2) signal via the adapter molec
215            Macrophage activation depended on Toll-like receptor 2 (TLR2) signaling, and cytokine prod
216 e the most potent microbial agonists for the Toll-like receptor 2 (TLR2) subfamily, and this pattern
217 nts with rosacea expressed higher amounts of Toll-like receptor 2 (TLR2) than normal patients.
218 shed work indicates that the contribution of Toll-like receptor 2 (TLR2) to host resistance during ac
219 ingivalis activate cross talk signaling from Toll-like receptor 2 (TLR2) to the beta2 integrin CD11b/
220                                              Toll-like receptor 2 (TLR2) was important to this proces
221 e ability of peptidoglycan (PGN) to activate Toll-like receptor 2 (TLR2) was recently questioned, we
222 olonization are in part due to activation of Toll-like receptor 2 (TLR2), a receptor for lipoproteins
223 crophages to produce TNF-alpha primarily via Toll-like receptor 2 (TLR2), although late pneumococcal
224        Both are ligands for the cell surface Toll-like receptor 2 (TLR2), and thus the contribution o
225 es of the putative GXM receptors CD14, CD18, Toll-like receptor 2 (TLR2), and TLR4 in GXM clearance f
226 es in the proinflammatory markers TNF-alpha, toll-like receptor 2 (TLR2), and TLR4.
227 ns of carboxyalkylpyrroles are recognized by Toll-like receptor 2 (TLR2), but not TLR4 or scavenger r
228 , the microbial pattern recognition receptor toll-like receptor 2 (TLR2), but not TLR4, was necessary
229 ipoproteins activate innate immune cells via Toll-like receptor 2 (TLR2), but TLR2-deficient mice are
230  tool in vivo by analysing the expression of toll-like receptor 2 (TLR2), corresponding to the microg
231 that the innate immune recognition receptor, Toll-like receptor 2 (TLR2), is crucial for inflammatory
232 ond to Pneumocystis murina organisms through Toll-like receptor 2 (TLR2), leading to the nuclear tran
233                  We found that RIP2, but not toll-like receptor 2 (TLR2), played a critical role in t
234  osteoclast modulation through engagement of Toll-like receptor 2 (TLR2), though the factors responsi
235  glucuronoxylomannan (GXM), is recognized by Toll-like receptor 2 (TLR2), TLR4, and CD14.
236 i-SBR immune response in mice and to require Toll-like receptor 2 (TLR2), TLR4, and MyD88 signaling f
237 ggering of mouse peritoneal neutrophils with Toll-like receptor 2 (TLR2), TLR4, and TLR9 ligands, but
238 ional type I IFN receptor but independent of Toll-like receptor 2 (TLR2), TLR4, TLR9, and the adapter
239  connect a key pattern recognition receptor, Toll-like receptor 2 (TLR2), to hyperbilirubinemia-induc
240                       In vitro activation of Toll-like receptor 2 (TLR2), up-regulated in ENL lesions
241 lipopeptide Pam3CysSK4, a popular agonist of Toll-like receptor 2 (TLR2), were designed making use of
242                                              Toll-like receptor 2 (TLR2), which increases CTMP induct
243                                              Toll-like receptor 2 (TLR2), which recognizes a range of
244 l" anti-inflammatory phenotype by activating Toll-like receptor 2 (TLR2), which regulates the inducti
245         We show that increased activation of Toll-like receptor 2 (TLR2)- and MyD88-dependent signali
246               Cytokine antibody arrays using toll-like receptor 2 (TLR2)- and TLR4-deficient macropha
247 he Brucella effector protein TcpB suppresses Toll-like receptor 2 (TLR2)- and TLR4-mediated innate im
248 n of macrophages derived from MyD88-, TRIF-, Toll-like receptor 2 (TLR2)-, TLR4-, and TLR2/4-deficien
249 and bacterial translocation were assessed in Toll-like receptor 2 (TLR2)-deficient and tumor necrosis
250 ural killer T cells, fails to enhance EAE in Toll-like receptor 2 (TLR2)-deficient mice and, in vitro
251  induces MCP-1 up-regulation in the SLFs via Toll-like receptor 2 (TLR2)-dependent activation of NF-k
252 es in infected macrophages are all driven by Toll-like receptor 2 (TLR2)-dependent activation of the
253 ral pathogen Porphyromonas gingivalis induce Toll-like receptor 2 (TLR2)-dependent macrophage activat
254 d COX2 expression, which were augmented in a Toll-like receptor 2 (TLR2)-dependent manner by macropha
255 a3 activation and P-selectin expression in a Toll-like receptor 2 (TLR2)-dependent manner.
256 ophilic pulmonary inflammation, mainly via a Toll-like receptor 2 (TLR2)-dependent mechanism.
257 n induces pathogenic host inflammation via a Toll-like receptor 2 (TLR2)-dependent pathway, resulting
258 nfected with LASV or with LCMV-WE suppressed Toll-like receptor 2 (TLR2)-dependent proinflammatory cy
259 matory reactions in gingival fibroblasts and Toll-like receptor 2 (TLR2)-dependent secretion of inter
260 ose-dependent NF-kappaB reporter activity in Toll-like receptor 2 (TLR2)-expressing HEK293T cells and
261 ibited responses to specific ligands for the Toll-like receptor 2 (TLR2)-TLR6 heterodimer.
262 any pattern recognition receptors, including Toll-like receptor 2 (TLR2).
263 ibition of osteoblasts through engagement of Toll-like receptor 2 (TLR2).
264 organisms, mediates inflammation through the Toll-like receptor 2 (TLR2).
265  decreased ability to activate NF-kappaB via Toll-like receptor 2 (TLR2).
266  (CMV) is initiated after its recognition by Toll-like receptor 2 (TLR2).
267 iduct pathology because it fails to activate Toll-like receptor 2 (TLR2).
268           This effect of SAA is dependent on Toll-like receptor 2 (TLR2).
269 nterleukin-10 (IL-10) through stimulation of Toll-like receptor 2 (TLR2).
270 88 (MyD88), TANK binding kinase 1 (TBK1), or Toll-like receptor 2 (TLR2).
271 elicit innate immune responses by activating Toll-like receptor 2 (TLR2).
272 in both human and mouse cells dependent upon Toll-like receptor 2 (TLR2).
273 hich occurred with exaggerated expression of Toll-like receptor 2 (TLR2).
274 ction with the pattern recognition receptor, Toll-like receptor 2 (TLR2).
275  is typically initiated by interactions with Toll-like receptor 2 (TLR2).
276 animal model for multiple sclerosis, through Toll-like receptor 2 (TLR2).
277 teraction between the viral glycoprotein and Toll-like receptor 2 (TLR2).
278 ylococcus aureus (S.a.), which are sensed by Toll-like receptor 2 (TLR2).
279 r glial fibrillary acidic protein (GFAP) and Toll-like receptor 2 (TLR2).
280 ability of aberrant forms of LOS to activate Toll-like receptor 2 (TLR2).
281 strated their differentiation in vitro after Toll-like receptor 2 (TLR2)/MyD88 stimulation.
282 own that curli fibrils are recognized by the Toll-like receptor 2 (TLR2)/TLR1 heterodimer complex.
283                                          The Toll-like receptor 2 (TLR2)/TLR1 receptor complex respon
284 ncoding the anti-apoptotic protein BIRC3 and Toll-like receptor 2 (TLR2); and the chromatin modifiers
285 ediated by the pathogen recognition receptor Toll-like receptor 2 (TLR2); furthermore, Legionella ind
286  stimulates the innate immune system through Toll-like receptor 2 (TLR2); however, the pathogen-assoc
287                            Mice deficient in Toll-like receptor 2 (TLR2-/-) or in B and T cells (scid
288 scle (ASM) cells, we show that activation of toll-like receptor 2 (TLR2; mimicking bacterial infectio
289          Rv1168c interacts specifically with Toll-like receptor-2 (TLR2) resulting in downstream acti
290 ty by increasing pattern recognition through Toll-like receptor-2 (TLR2), and increasing the expressi
291 ast, when we transferred neutrophils lacking Toll-like receptor-2 (TLR2), TLR3, TLR4, TLR7 and TLR9,
292 attern recognition receptor dectin-1 but not Toll-like receptor-2 (TLR2), zymosan-mediated RGC regene
293 his article, we show that germ-free (GF) and Toll-like receptor-2 (Tlr2)-deficient mice have reduced
294      Emerging reports reveal that activating Toll-like receptor-2 (TLR2)-MyD88 signals in CD8 T lymph
295                  Upon microbial infection or Toll-like-receptor 2 (TLR2) activation, Rubicon interact
296 ced early during IAPP aggregation provided a Toll-like-receptor-2- (TLR2-) dependent stimulus for NF-
297 e I interferon (IFN) signaling downstream of Toll-like receptor 2/Toll-like receptor 4 activation in
298 mphoblastoid cell lines (LCLs) partially via Toll-like receptor 2 triggering, as did purified GAS pep
299 gamma (IFN-gamma), interleukin-6 (IL-6), and toll-like receptor 2 (TRL-2).
300                                              Toll-like receptor 2 was shown to be activated in AD les

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top